Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients

類似資料

• Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients
  著者:: Simeone, Ester, 等
  出版事項: (2015)
• Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma
  著者:: Simeone, Ester, 等
  出版事項: (2017)
• Serious haematological toxicity during and after ipilimumab treatment: a case series
  著者:: Simeone, Ester, 等
  出版事項: (2014)
• Do BRAF inhibitors select for populations with different disease progression kinetics?
  著者:: Ascierto, Paolo Antonio, 等
  出版事項: (2013)
• Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
  著者:: Grimaldi, Antonio M, 等
  出版事項: (2014)